Add BrightSurf on Google Email

Science News for August 31, 2019


New guidance on potentially fatal blood clots published today

The new guidelines clarify the diagnosis and treatment of acute pulmonary embolism, emphasizing the importance of quick and reliable diagnosis to prevent death. The guidance also provides recommendations on the use of anticoagulant drugs and clot busters, as well as distinguishing between fresh thrombi and chronic obstructions.

SourceEuropean Society of Cardiology·DateAug 31, 2019
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

4TEEN4 Pharmaceuticals reports first results on Procizumab

Procizumab shows high therapeutic potential in treating acute heart failure and cardiogenic shock by targeting the DPP3 enzyme. The company is setting up GMP process for Procizumab manufacturing and expects to enter regulatory non-clinical safety studies next year.

Source4TEEN4 Pharmaceuticals GmbH·JournalEuropean Journal of Heart Failure·DateAug 31, 2019

Cardiovascular disease patients benefit more from exercise than healthy people

A study of nearly half a million people found that those with heart or blood vessel problems benefited more from having a physically active lifestyle than healthy people without cardiovascular disease. Increased physical activity reduced the risk of dying during a six-year follow-up period for people with and without CVD.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateAug 31, 2019

Diabetes medication shows potential to reduce heart disease

A new study suggests that a diabetes medication called empagliflozin can protect against heart disease by regulating circulating progenitor cells and reducing inflammation. The findings from the EMPA-HEART CardioLink-6 Trial may provide the basis for new therapies for patients with heart disease complicated by diabetes.

SourceSt. Michael's Hospital·JournalCell Metabolism·DateAug 31, 2019
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Tiny wearable cameras may improve quality of life in heart failure patients

Researchers developed a tiny wearable camera to track heart failure patients' daily activities, providing valuable data for fine-tuning self-management. The study found that the cameras could identify areas for improvement in diet, exercise, and medication adherence, with potential applications for guiding newly diagnosed patients.

SourceEuropean Society of Cardiology·DateAug 31, 2019

Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression

A novel disease mechanism links circulating DPP3 to cardiac and renal dysfunction, with sustained high DPP3 levels associated with reduced cardiac function, impaired kidney function, and increased mortality. The DPP3 biomarker has high potential utility in diagnosing organ dysfunction and predicting outcomes in cardiogenic shock patients.

Sourcesphingotec GmbH·JournalEuropean Journal of Heart Failure·DateAug 31, 2019
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Microbes may play a role in heart attack onset

A study found that bacteria in coronary plaques were pro-inflammatory, whereas gut bacteria were diverse and varied. Patients with acute coronary syndrome had different gut microbiota compared to those with stable angina. The research suggests a possible role for microbes in plaque destabilization and heart attack onset.

SourceEuropean Society of Cardiology·DateAug 31, 2019

Eating nuts linked with lower risk of fatal heart attack and stroke

A recent study found that eating nuts at least twice a week is associated with a lower risk of death from cardiovascular disease. The researchers analyzed data from 5,432 Iranian adults and found that nut consumption was linked to a 17% reduced risk of fatal heart attack and stroke.

SourceEuropean Society of Cardiology·DateAug 31, 2019

Aspirin should not be recommended for healthy people over 70

A sub-group analysis from the ASPREE trial found that daily low-dose aspirin did not prolong disability-free survival in healthy people over 70, even in those at high cardiovascular disease risk. The study suggests that improved risk prediction methods are needed to identify those who could benefit from aspirin therapy.

SourceEuropean Society of Cardiology·DateAug 31, 2019

Guidelines on diabetes and cardiovascular diseases published today

The guidelines emphasize healthy behaviors, such as physical activity and a Mediterranean diet, to prevent cardiovascular disease. They also recommend specific medications, including GLP-1 receptor agonists and PCSK9 inhibitors, for patients with diabetes at high risk of cardiovascular disease.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateAug 31, 2019
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Motivational text messages help patients with diabetes

A low-cost text-messaging programme improves blood sugar control in patients with diabetes and coronary heart disease. The programme, which consisted of six messages per week, resulted in a significant reduction in HbA1c levels and an increase in participants achieving the target level of less than 7%.

SourceEuropean Society of Cardiology·DateAug 31, 2019

Guidelines on management of fast heartbeat published today

The European Society of Cardiology has published new guidelines for the management of fast heartbeat, highlighting the benefits of catheter ablation in treating supraventricular tachycardia. The guidelines recommend invasive methods for eradicating arrhythmias and provide specific recommendations for pregnant women.

SourceEuropean Society of Cardiology·DateAug 31, 2019